Effect of indomethacin on increased resistance to bacterial infection and on febrile responses induced by muramyl dipeptide.
The pyrogenicity in the rabbit and the ability to stimulate nonspecific resistance to bacterial infection in the mouse of muramyl dipeptide (MDP), a synthetic immunoadjuvant, are known to be enhanced when the glycopeptide has been conjugated to a carrier. The effects of indomethacin on fever induced by MDP or its conjugated derivative were studied. Indomethacin reduced febrile responses to MDP or its derivative, although it did not decrease production of endogenous pyrogen in vivo or in vitro. When incubated with rabbit peritoneal cells, indomethacin suppressed the elevation in prostaglandin levels usually induced by MDP. When administered to mice, indomethacin alone stimulated resistance to bacterial infection and, under appropriate conditions, had a strong synergistic effect when combined with free or conjugated MDP. The results demonstrate that neither pyrogenicity nor increased prostaglandin levels are prerequisites for immunopotentiation by synthetic glycopeptides.
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000494:pharmacology*; D000818:Animals; D004357:Drug Synergism; D005334:Fever / Q000139:chemically induced / Q000188:drug therapy*; D006020:Glycopeptides / Q000494:pharmacology*; D007113:Immunity, Innate / Q000187:drug effects*; D007213:Indomethacin / Q000494:pharmacology*; D007710:Klebsiella Infections / Q000276:immunology; D007958:Leukocyte Count; D008088:Listeriosis / Q000276:immunology; D008297:Male; D011453:Prostaglandins / Q000032:analysis; D011817:Rabbits
D006020:Glycopeptides; D011453:Prostaglandins; D000119:Acetylmuramyl-Alanyl-Isoglutamine; D007213:Indomethacin